Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Cancer Incidence in Swedish Sterilant Workers Exposed to Ethylene Oxide

Lars Hagmar, Zoli Mikoczy and Hans Welinder
Occupational and Environmental Medicine
Vol. 52, No. 3 (Mar., 1995), pp. 154-156
Published by: BMJ
Stable URL: http://www.jstor.org/stable/27730286
Page Count: 3
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Cancer Incidence in Swedish Sterilant Workers Exposed to Ethylene Oxide
Preview not available

Abstract

Objectives—To assess the risk of cancer, especially leukaemia, in a cohort of sterilant workers exposed to ethylene oxide (EtO). Methods—A cohort of 2170 workers employed for at least one year in two plants that produce disposable medical equipment sterilised with EtO has previously been established. The results of update with four more years of observation are presented. The cancer incidence was assessed for the periods 1976 to 1990 and 1972 to 1990 and cause specific standardised incidence ratios (SIRs) were calculated. Individual cumulative exposure to EtO, expressed as ppm-years, was estimated and used in exposure-response analyses. Results—Six lymphohaematopoietic tumours were observed (SIR 1·78, 95% confidence interval (95% CI) 0·65–3·88), of which two were leukaemias (SIR 2·44; 95% CI 0·30–8·81). When those with cumulative exposures to EtO below the median value (0·13 ppm-years) were excluded, and a minimum of 10 years induction latency period was applied, the incidence ratio for leukaemia increased further (SIR 7·14, 95% CI 0·87–25·8), but was still not significantly enhanced. Conclusions—The risk estimate for leukaemia increased, but non-significantly, with time since start of exposure, and with cumulative exposures to EtO above the median value. The subjects with leukaemia had, however, only slightly higher cumulative exposure estimates for EtO than the average cohort member. Nevertheless, the present results may add some minor evidence for an association between EtO and an increased risk of leukaemia.

Page Thumbnails

  • Thumbnail: Page 
154
    154
  • Thumbnail: Page 
155
    155
  • Thumbnail: Page 
156
    156